Kemet Group, through its division KemNet, is a healthcare startup that is revolutionizing the pharmaceutical industry by providing custom medication solutions tailored to individual patient needs. This Edmonton, Canada-based company, founded in 2022 with a small team, is at the forefront of personalized medicine, making significant strides in the way drugs are reformulated and distributed.
Innovations in Personalized Medicine
Kemet Group’s approach to healthcare is innovative and patient-centric. They specialize in connecting individuals with pharmacies capable of creating customized medications. This includes unique dosages, formulations, and solutions for out-of-stock medications, exclusively serving residents of Alberta. Their pioneering work has not gone unnoticed, as they have garnered several prestigious awards, including the 2021 MIT Solve Global Challenges Award for Health Security & Pandemics, a second place in the 2022 Zeton/CSChE Plant Design Competition, and recognition from the University of Alberta’s Faculty of Pharmacy & Pharmaceutical Science.
KemNet’s Role in Drug Reformulation
KemNet, a key component of Kemet Group, specializes in supplying pharmacies with premium reformulations of popular drugs tailored for specific patient groups. These reformulated products address various health issues, such as erectile dysfunction, hair growth, pain management, weight loss, and women’s health. Notably, their erectile dysfunction medications are acclaimed for being up to eight times faster than traditional alternatives. This innovative approach is not only beneficial for patients but also advantageous for pharmacies, contributing to their financial growth.
Founder’s Vision and Expertise
The vision behind KemNet is driven by Morẹ́nikẹ́ Ọláòṣebìkan, a licensed clinical pharmacist and pharmacy proprietor. Her role as a Clinical Academic Colleague at the Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, highlights her commitment to advancing the field of pharmacy through innovative practices. Her leadership has been instrumental in developing KemNet as a platform for pharmacies to access these specialized medications.
Business Model and Patient Empathy
KemNet operates with a unique business model, positioning itself as the “Amazon” for customized medications. This model emphasizes empathy in patient care, leading to the development of medications that are not only effective but also enjoyable to use, with reduced side effects. The company’s focus on empathetic design in medication formulation, derived from Ọláòṣebìkan’s experience as a multi-pharmacy owner, has proven to be a successful strategy for both patient care and business growth.
Summary
Kemet Group, through KemNet, exemplifies the potential of personalized medicine in improving patient care and pharmacy practices. Their innovative approach to drug reformulation and distribution, combined with a strong emphasis on patient empathy, positions them as a trailblazer in the healthcare industry. With their unique solutions and patient-centered approach, Kemet Group is set to continue making significant contributions to personalized healthcare and pharmacy services.